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Histamine Upregulates Keratinocyte MMP-9
Production via the Histamine H1 Receptor
Maria Gschwandtner1, Rahul Purwar1, Miriam Wittmann1, Wolfgang Ba¨umer2, Manfred Kietzmann2,
Thomas Werfel1 and Ralf Gutzmer1
Skin inflammation and the migration of cells at the site of the immune response play an important role in
allergic skin diseases. It has already been described that matrix metalloproteinase 9 (MMP-9) influences tissue
remodeling and facilitates cell migration by proteolytic degradation of basal membrane components. The aim of
this study was to investigate MMP-9 expression on human primary keratinocytes (KCs) upon stimulation with
histamine, a potent mediator in allergic responses. With ELISA and zymography, we could show that histamine
induced dose-dependent upregulation of MMP-9 in cultured KCs and in punch biopsies of human skin. The
histamine H1 receptor (H1R) agonist b-histine—but not agonists for H2R, H3R, and H4R—induced MMP-9,
whereas the H1R antagonist clemastine blocked the effect in a dose-dependent manner. Immunohistological
staining showed that histamine-induced MMP-9 led to destruction of type IV collagen at the basement
membrane in healthy skin. In a coculture system of KCs and T cells, migration of T cells through an artificial
basement membrane was increased after histamine stimulation of KCs. Our findings demonstrate enhanced
MMP-9 production and cell migration after histamine stimulation and may represent a new mechanism by
which KCs contribute to the pathology of skin diseases.
Journal of Investigative Dermatology (2008) 128, 2783–2791; doi:10.1038/jid.2008.153; published online 12 June 2008
INTRODUCTION
Histamine is an important immunomodulatory mediator that
plays a role in immediate-type allergic reactions such as
allergic rhinitis. Recent studies also suggest a role of
histamine in delayed-type allergic responses as seen in atopic
dermatitis and contact allergy, as T cells and antigen-
presenting cells express functional histamine receptors (Jutel
et al., 2001; Gutzmer et al., 2002). Histamine is mainly
stored in mast cells and basophils and is released upon
crosslinking of the IgE receptors. Once released, histamine
can act on four known G-protein coupled transmembrane
receptors: histamine H1 receptor (H1R), H2R, H3R, and H4R
(Leurs et al., 1995; Bakker et al., 2002). Histamine receptors
are functionally expressed on various cell types involved
during inflammation, including monocytes (Dijkstra et al.,
2007), lymphocytes (Sachs et al., 2000), monocyte-derived
dendritic cells (Gutzmer et al., 2005), and keratinocytes
(Giustizieri et al., 2004). The latter represent the main cell
population in the skin and establish the local cytokine and
chemokine milieu, which is necessary for attracting other
cells participating in an immune response. Several research
groups could show mediation of inflammatory actions via
histamine on human keratinocytes. The effects mainly
involve H1R activation, which suggests that this receptor is
primarily responsible for immunomodulatory actions on
keratinocytes. Described so far is the regulation of IL-6,
IL-8, GM-CSF, CCL5, and nerve growth factor production
(Kohda et al., 2002; Kanda and Watanabe, 2003, 2004;
Giustizieri et al., 2004) and modulation of surface molecules
ICAM-1, HLA-DR, and MHC-I (Giustizieri et al., 2004). This
emphasizes the important role of histamine as a mediator in
allergic diseases, as all of these molecules play a crucial role
in their development and progression. Another mediator
implied in skin pathologies is matrix metalloproteinase 9
(MMP-9), which has been found to be increased in lesions
of psoriasis (Suomela et al., 2001; Purwar et al., 2008),
keratinocytes after UVB irradiation (Onoue et al., 2003), and
allergic contact dermatitis (Giannelli et al., 2002). Therefore,
we were interested in examining the effect histamine has
on this protease in cultured human keratinocytes and the
impact in allergic skin diseases.
Matrix metalloproteinase 9 (also known as 92 kDa
gelatinase and type IV collagenase) belongs to the family of
zinc-dependent proteinases (Goetzl et al., 1996) and can
cleave gelatins, type IV collagen, fibronectin, laminin, and
elastin (Birkedal-Hansen, 1995). As most of these substrates
are predominantly found at the basement membrane, MMP-9
is of particular interest in inflammatory skin diseases, where
migration of cells across the basal layer to enter and leave the
site of inflammation is required. For various cell types
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relevant in inflammatory skin diseases, the ability to
produce MMP-9 has been shown: epidermal keratinocytes
(Kobayashi, 2005), Langerhans cells (Ratzinger et al., 2002),
mast cells (Kanbe et al., 1999), T cells (Leppert et al., 1995),
and eosinophils (Schwingshackl et al., 1999) can produce
MMP-9 facilitating transmigration through the basement
membrane. As histamine is an important mediator in allergic
reactions, we were interested in its influence on MMP-9. We
focused our work on keratinocytes, as they represent the
major resident cellular component of the skin and therefore
might be important in the regulation of basement membrane
destruction. Aware of that background, we hypothesize that
histamine is able to regulate MMP-9 production in human
primary keratinocytes.
RESULTS
Histamine leads to dose- and time-dependent upregulation of
MMP-9 via the H1R receptor
Human primary keratinocytes (KCs) were already shown
to produce MMP-9 spontaneously and upon stimulation
(Han et al., 2001; Kobayashi, 2005; Purwar et al., 2008). To
investigate the effect of histamine on MMP-9 production and
to determine which histamine receptor mediates this effect,
KCs were subjected to stimulation with 10 mM of histamine or
specific agonists for the four different receptors. Histamine
and the selective H1R agonist b-histine lead to a significant
upregulation of MMP-9 production in KCs, whereas agonists
to the other three histamine receptors—dimaprit (H2R),
methimepip (H3R), 4-methylhistamine (H4R)—had no effect
(Figure 1a). We used tumor growth factor (TGF)-b1 as positive
control, as it has been shown to upregulate MMP-9 (Salo
et al., 1991). Moreover, an additive effect of TGF-b1 in
combination with histamine receptor agonists was observed
(Figure 1b). The induction of MMP-9 was dose dependent,
with histamine having higher efficacy than b-histine (Figure
2a and b). For the other histamine receptor agonists, no dose
dependency was observed; three doses in the range from 1 to
100mM did not induce MMP-9 (data not shown). The
upregulation of MMP-9 was as well dependent on time, with
a significant increase in mRNA and protein detected after 12,
24, and 48 hours of stimulation (Figure 2c and d).
To show that the effect is specific for H1R, the selective
H1R antihistamine clemastine hydrogen fumarate, which
acts as an inverse agonist and thereby reduces constitutive
receptor activity (Leurs et al., 2002), was used. Whereas
histamine and the H1R agonist b-histine lead to upregulation
of MMP-9 (Figure 3a), 30minutes pre-incubation of the cells
with clemastine before receptor stimulation blocked the
increase in MMP-9, showing that the effect is specific for H1R
(Figure 3b). The blocking effect of clemastine was dose
dependent and showed very high efficacy (Figure 3c). As
clemastine could decrease the level of MMP-9 in histamine-
stimulated cells to basal expression, the effect seemed to be
mediated exclusively by H1R. To further evaluate the role of
other histamine receptors, antagonists specific for H2R, H3R,
and H4R were used and shown to result in no abolition of
histamine-induced MMP-9 upregulation (Figure 3d), whereas
in addition to clemastine (Figure 3b), the new-generation H1R
antihistamine levocetirizine also had blocking function
(Figure 3d). Owing to these observations, it can be concluded
that H1R is the mediating receptor and that the other
receptors (H2R–H4R) play no role in the induction of MMP-9.
Exogenous and endogenous histamine leads to increased
MMP-9 production in healthy skin
In addition to cultured KCs, we were also interested in the
effect of histamine on MMP-9 production in skin samples.
Therefore, punch biopsies of healthy skin were stimulated
with histamine for 16 hours; thereafter, a homogenate was
prepared and protein was extracted. To demonstrate the
induction of MMP-9 in these skin homogenates, they were
subjected to zymography on gels containing gelatin as
substrate for MMP-9. MMP-9 can appear on the zymography
gel in two bands, 92 kDa (inactive pro-form) and 72 kDa
(active form). After stimulation with histamine, a higher level
of MMP-9 could be detected, resulting in a more intense
band due to degradation of the gelatin (Figure 4a). In
addition, another band of smaller size appeared in the
H
4R
 a
go
ni
st
H
3R
 a
go
ni
st
H
2R
 a
go
ni
st
H
1R
 a
go
ni
st
H
is
ta
m
in
e
N
S
TG
F-
β1
H
4R
 a
go
ni
st
H
3R
 a
go
ni
st
H
2R
 a
go
ni
st
H
1R
 a
go
ni
st
H
is
ta
m
in
e
N
S
+ TGF-β1
0
1,000
2,000
3,000
4,000
5,000
M
M
P-
9/
TI
M
P-
1 
(pg
 m
l–1
)
M
M
P-
9/
TI
M
P-
1 
(pg
 m
l–1
) *
*
**
**
*1,500
1,000
500
0
Figure 1. Histamine and the H1R agonist b-histine induce MMP-9 in keratinocytes. (a) Histamine (10 mM) and b-histine (10mM) induce MMP-9 production
in keratinocyte supernatants after 48 hours of stimulation. (b) Additive effect of TGF-b1 (1 ngml1) and histamine in the upregulation of MMP-9. Mean
and SEM of (a) 11 and (b) 7 independent experiments are shown.
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stimulated samples, indicating that another gelatinase was
also induced in the skin after histamine stimulation. To
evaluate if endogenous histamine released from mast cells in
the skin can also lead to an increase in MMP-9 production,
biopsies were incubated with the mast cell-degranulating
agent compound 48/80 without addition of exogenous
histamine. Treatment with compound 48/80 lead to induction
of MMP-9 comparable in amount with histamine-stimulated
biopsies. The increase in MMP-9 could be blocked by
30minutes pre-incubation of the skin samples with the H1R
antagonist clemastine (Figure 4a). Furthermore, the results of
ELISA could be confirmed with zymography, as supernatants
of cultured KCs stimulated with histamine and/or TGF-b1
showed increased gelatinolytic activity (Figure 4b). Owing to
the size of the bands, it can be concluded that only the
inactive pro-form of MMP-9 (92 kDa) was detected in
zymograms.
To confirm the results of zymography, immunohistological
staining of skin sections was performed to detect the
increase of MMP-9 with specific antibodies. As depicted in
Figure 5a–c, skin treated with histamine showed more intense
staining for MMP-9 as compared with nonstimulated control
skin.
Breakdown of type IV collagen at the basement membrane
To evaluate if histamine has an influence on the structure of
the basement membrane, immunohistological staining
of type IV collagen in sections of healthy skin cultured with
or without histamine was performed. In histamine-stimulated
skin, the amount of type IV collagen, the major structural
component at the basal lamina, was decreased as compared
with the untreated control (Figure 5d–f), suggesting that
histamine-induced MMP-9 degrades the basement membrane
and thereby makes it easier accessible for cell transmigration.
This assumption is supported by inhibited degradation of type
IV collagen in histamine-stimulated skin after treatment with
the MMP inhibitor GM6001, whereas a control substance
had no effect (Figure 5g and h).
Induction of T cell migration across artificial basement
membrane
As immunohistological staining showed that histamine
reduces the amount of type IV collagen at the basal lamina,
we decided to investigate if H1R-induced MMP-9 facilitates
migration of T cells across an artificial basement membrane
in vitro. KCs were grown on 8 mm membrane inserts covered
with a matrix containing type IV collagen, laminin, and other
components of the basal lamina. KCs were stimulated for
30 hours with histamine or left untreated; thereafter, the
stimulus was removed and the medium was replaced with
fresh medium. Jurkat T cells were added into the insert and
chemoattractants were given to the lower chamber to induce
migration of the cells across the membrane. After histamine
stimulation of the KCs, a higher degree of migration across
the membrane was observed as compared with nonstimu-
lated controls (Figure 6a), indicating that the artificial
basement membrane was degraded to a higher extent.
Presence of the MMP inhibitor GM6001 (Figure 6b), but
not of the control reagent (Figure 6c), abolished the histamine
effect. We could also demonstrate an increase in migration if
freshly isolated CD4þ T cells, instead of the Jurkat T cells,
were used (data not shown).
DISCUSSION
Previously, it has been already shown that keratinocytes
express H1R and that it plays an important role in
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Figure 2. Dose and time dependency of MMP-9 induction. Dose–response curve of MMP-9 production for (a) histamine and (b) b-histine. Basal level of
MMP-9 production in nonstimulated controls was (a) 910 pgml1 and (b) 827 pgml1. Time course of MMP-9 induction by histamine (10 mM); mRNA
levels determined by (c) quantitative RT-PCR and protein levels measured in (d) ELISA are plotted. Mean and SEM of (a, b) 3, (c) 7, and (d) 6 independent
experiments are shown.
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inflammatory processes (Kohda et al., 2002; Giustizieri et al.,
2004; Kanda and Watanabe, 2004). In addition, several
mediators of inflammation, tumor necrosis factor-a, TGF-b1,
IL-13, and IL-1b, were identified to regulate the production of
MMPs (Lyons et al., 1993; Han et al., 2001; Purwar et al.,
2008), which have a pivotal role during the tissue infiltration
process of immune cells.
Here, we show that the level of MMP-9 production in KCs
can be directly influenced by stimulation of H1R. In cultured
KCs, dose- and time-dependent upregulation of MMP-9 by
histamine and H1R agonist b-histine was detected. The H1R
antihistamines clemastine and levocetirizine reduced the
level of MMP-9 back to basal expression, whereas antagonists
at the other three histamine receptors had no effect, proving
that the MMP-9 induction can be ascribed to H1R and
indicating that the other histamine receptors (H2R–H4R) play
no role in the regulation of this protease. These results are
consistent with a recent report by Asano et al. (2004) that the
histamine H1R antagonist fexofenadine hydrochloride can
block the production of metalloproteinases MMP-2 and
MMP-9 in nasal fibroblasts and thereby possibly reduce the
severity of allergic rhinitis, which is characterized by
remodeling of the nasal wall and eosinophil and mast cell
infiltration.
Moreover, we could show an increase in MMP-9
production in skin biopsies, where KCs were studied ex vivo,
which was induced by exogenous as well as endogenous
histamine released after mast cell degranulation. However,
owing to the detected protein sizes in zymogram gels, only
the pro-form of MMP-9 and not the activated protease was
present in the samples. Similarly, other groups could show
functional effects, although no active form of MMP-9 could
be detected (Aoudjit et al., 1999; Liu et al., 2000; Nold et al.,
2003). This observation might be explained by the lack of
activating agents, like MMP-3 (Ogata et al., 1992), MMP-2
(Fridman et al., 1995), MMP-7 (von Bredow et al., 1998), and
MMP-13 (Knauper et al., 1997), which usually cleave MMP-9
to its active form or other nonfavorable conditions during
culture (Fridman et al., 2003). Recently, it was also described
that activation of MMP-9 might not need cleavage of the
propeptide, as there exists an alternative way in which the
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Figure 3. Specific H1R antagonists clemastine and levocetirizine diminish
induction of MMP-9. (a) Upregulation of MMP-9 by histamine and H1R
agonist b-histine. (b) Upregulation is blocked by 30minutes preincubation
with H1R-specific antagonist clemastine hydrogen fumarate (10 mM).
(c) Dose–response of b-histine-stimulated cells to clemastine. (d) H1R
antagonist levocetirizine, but not H2R antagonist ranitidine and H3R and
H4R antagonist thioperamide, can block histamine-induced MMP-9
production. Mean and SEM of (a, b) 10, (c) 2, and (d) 6 independent
experiments are depicted.
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Figure 4. Histamine induces MMP-9 as determined by gelatin zymography.
(a) Zymogram of healthy skin homogenates shows increase in MMP-9
levels by histamine (2) as compared to nonstimulated control (1). Endogenous
histamine released from mast cells after compound 48/80 (0.3mM) treatment
leads to MMP-9 upregulation (3) that can be blocked by 30minutes
pre-incubation with 10mM H1R-specific antagonist clemastine (4).
(b) Zymogram of keratinocyte supernatants: nonstimulated (1), stimulated
with histamine (2), TGF-b1 (3), or histamine plus TGF-b1 (4). One
representative analysis of (a) 2 and (b) 3 independent experiments is shown.
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gelatinase is activated by binding to its substrate (Bannikov
et al., 2002). Thus, lack of the activated form in zymogram
does not necessarily exclude functional MMP-9.
As biological effects of MMP-9 upregulation, we could
show that histamine stimulation leads to degradation of
type IV collagen at the basement membrane in healthy
skin samples. Degradation of type IV collagen and other
structural proteins also facilitated T cell migration across an
artificial basement membrane. However, the effect cannot be
attributed to MMP-9 without remarks, as the block of type IV
collagen degradation and increased migration was shown
by the broad spectrum MMP inhibitor GM6001, which
inhibits in addition to MMP-9 also MMP-1, MMP-2, MMP-3,
and MMP-8. All of these proteases are expressed at basal
level in keratinocytes (Bachmeier et al., 2000a, 2000b), and
MMP-2 and MMP-3 both degrade type IV collagen and there-
fore could contribute to the effects seen in histology and
transmigration assays.
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Figure 5. Increase in MMP-9 and destruction of type IV collagen at the basement membrane after histamine stimulation. Immunohistological staining
shows increased amount of (a–c) MMP-9 and (d–f) decreased amount of type IV collagen at the basement membrane after histamine stimulation. (a,d) Nontreated
skin, (b, e) skin treated with 10 mM histamine, (c, f) isotype staining. (g) MMP inhibitor GM6001 blocks histamine induced destruction of type IV collagen,
but not its (h) negative control. One representative analysis of (a–c) 8 and (d–h) 3 independent experiments is depicted.
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Figure 6. Induction of T cell migration across an artificial basement membrane. (a) Prestimulation of keratinocytes with 10 mM histamine upregulates
the migration of Jurkat T cells across an artificial basement membrane in a coculture system. Increased migration is blocked by (b) MMP inhibitor GM6001 but
not its (c) negative control. A total of 10 000 beads were counted and the cells/bead ratio of (a) 9 and (b, c) 7 independent experiments was calculated.
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Another interesting observation in zymogram of skin
samples was that an additional protease band after histamine
stimulation was detected in gelatin gels. This could be one of
the proteases mentioned above, because MMP-2 as well as
MMP-3 cleave gelatin. Both are also capable of activating
pro-MMP-9 (Ogata et al., 1992; Fridman et al., 1995), there-
fore, it could be possible that histamine induces also MMP-2
and/or MMP-3 along with MMP-9, which then activates the
increased amount of MMP-9. Owing to the molecular weight
of the band in zymogram, we speculate that it could be
MMP-2 (72 kDa gelatinase). Moreover, MMP-2, similar to
MMP-9, was shown to be increased in the challenge phase of
allergic contact dermatitis (Giannelli et al., 2002) and to be
decreased by H1R antagonist in nasal fibroblasts (Asano et al.,
2004). However, further investigations are needed to
determine the identity of the detected protease and if it has
direct action on the degradation at the basement membrane
or is only responsible for the cleavage of pro-MMP-9.
During inflammation, the migration of cells across the
basal lamina is an important process that is controlled by the
composition of the basement membrane and the balance of
proteases, cytokines, and chemokines. MMPs have influence
on all these parameters and were shown to have high
expression levels in human pathologies, such as in lesional
acute eczema (Purwar et al., 2008), severe asthma (Wenzel
et al., 2003), and upon allergen challenge in the lung
(Kelly et al., 2000). MMP-9 can affect the process of tissue
remodeling not only by cleaving type IV collagen and thereby
improving cell migration, but also by influencing the levels of
cytokines by proteolytic processing (Atkinson and Senior,
2003; Greenlee et al., 2006). The role and specific actions of
MMP-9 in tissue remodeling during skin pathologies were
studied in models using MMP-9-deficient mice. In contact
hypersensitivity models, MMP-9 knockout mice were shown
to have a similar response to DNFB challenge as wild-type
mice. However, the ear thickness was increased for a longer
time period after challenge and inflammatory cell infiltration
was persistent, indicating that the response in MMP-9
knockout mice was prolonged as compared with wild-type
mice (Wang et al., 1999). In contrast to MMP-9-deficient
mice, MMP-3 knockouts showed an impaired contact
hypersensitivity response (Wang et al., 2001); therefore,
MMP-3 seems to play a critical role in the initiation of contact
hypersensitivity and MMP-9 in its resolution. During wound
closure, the application of a broad spectrum MMP inhibitor at
wounds in humans leads to increased levels of pro-MMP-9
and prevention of MMP-2 activation, resulting in a delayed
healing process (Agren et al., 2001). A study in mice
showed that deficiency of MMP-9 accelerates the rate of
wound closure (Mohan et al., 2002). These results show
that MMPs can play different roles in disease in humans and
mice; and that the balance of the proteases with respect to
time and location as well as the surrounding environment is
important in determining the performed action. However,
studies in knockout mice show that MMP-9 has many
functions during inflammatory reactions and therefore plays
an important role in development and progression of allergic
skin diseases.
Not only animal models but also studies with human
material demonstrate that MMP-9 plays a role in allergic
diseases in the skin. Recently, it was shown that in lesions of
atopic dermatitis patients, mast cells migrated from the dermis
into the epidermis passing the basement membrane (Grone-
berg et al., 2005). The ability of mast cells to migrate through
the basal lamina is probably influenced by MMP-9, which was
described to be produced and also activated by mast cells
(Kanbe et al., 1999). Not only mast cells, but also Langerhans
cells, which play a role in inflammatory responses, produce
MMP-9 (Ratzinger et al., 2002) to facilitate their migration
across the basal lamina. We could now show that KCs produce
MMP-9 in response to H1R stimulation, which results in
destruction of type IV collagen at the basement membrane
and increased migration of T cells across the basal lamina in
in-vitro experiments. During an allergic immune response,
histamine is mainly set free from storage granules of mast cells,
which themselves produce MMP-9 (Kanbe et al., 1999). The
release of histamine stimulates in addition the production of
this protease in the tissue-resident KCs and therefore leads to
an amplification of MMP-9-mediated effects. As KCs are the
major constituent of the skin, they might play an important role
in regulating the migration of nonresident cells at the site of
inflammation. MMP-9 produced by KCs might not only lead to
destruction of structural proteins at the basement membrane,
as shown in this article, but can also influence the chemokine
gradients. Further investigations are needed to understand
the effect of histamine on the levels of these mediators and
the resulting attraction of immune cells.
The findings of our work could be of interest for the
treatment of allergic skin diseases, as antagonistic agents at the
H1R on KCs could decrease the levels of MMP-9 released after
histamine stimulation and therefore diminish the destruction of
the basement membrane and the resulting increased cell
migration. As the modulation of cell migration is regulated by
a complex network of protease and chemokine expression, the
interplay between various cells might be of importance.
Therefore, the effects of H1R on MMP-9 production should
also be investigated in other cells participating in an allergic
response that were shown to express the receptor.
MATERIALS AND METHODS
Keratinocyte isolation and culture
Human primary keratinocyte cultures were prepared from foreskin as
described previously (Wittmann et al., 2005). The foreskin was cut
into pieces and incubated overnight at 41C in 2.4U dispase II
(Roche, Mannheim, Germany). The next day, the epidermis was
separated from the dermis and placed for 20minutes at 371C in
EDTA (0.02%)-trypsin (0.05%) solution (PAN-Biotech, Aidenbach,
Germany). After stopping the trypsin reaction by addition of fetal calf
serum (PromoCell, Heidelberg, Germany), the cell suspension was
filtered through a sterile gauze (40 mm) and washed two times in
PBS. The obtained single-cell suspension of KCs was incubated in
serum-free growth medium, Keratinocyte Growth Medium 2 Kit
(PromoCell, Heidelberg, Germany), at 371C in a humidified atmo-
sphere containing 5% CO2. For experiments, KCs in passage 3–6
cultured in hydrocortisone and epidermal growth factor-free
medium were used.
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Jurkat cell line
The human T lymphocyte cell line derived from a male patient with
acute T cell leukemia was grown at concentrations between 1 105
and 1 106 cellsml1. Jurkat cells were cultured in RPMI 1640
supplemented with 2mM L-glutamin, 100mgml1 penicillin/strepto-
mycin, 1 nonessential amino acids, 0.05mgml1 gentamicin, and
6% v/v fetal calf serum. Media and supplements were purchased
from Biochrom AG (Berlin, Germany).
Reagents
Various histamine receptor ligands were used in this study: histamine
(agonist for all histamine receptors, Alk-Scherax, Wedel, Germany),
b-histine (H1R agonist, Sigma-Aldrich, Deisenhofen, Germany),
dimaprit (H2R agonist, Sigma-Research Biotechnology), methimepip
(H3R agonist, kindly provided by R Leurs, Vrije Universiteit
Amsterdam, Netherlands (Kitbunnadaj et al., 2005)), 4-methylhista-
mine (H4R agonist, provided by R Leurs (Lim et al., 2005)),
clemastine (H1R antagonist, Novartis, Nu¨rnberg, Germany), raniti-
dine (H2R antagonist, Biomol, Hamburg, Germany), thioperamide
(H3R and H4R antagonist, Sigma-Aldrich), and levocetirizine (H1R
antagonist, UCB Pharma, Kerpen, Germany). The mast cell degra-
nulating agent compound 48/80 was obtained from Sigma-Aldrich.
TGF-b1 was purchased from PromoCell (Heidelberg, Germany). The
recombinant human proteins CCL2 (MCP-1), CCL22 (MDC),
and CXCL10 (IP-10) used in transbasement membrane migration
assays were obtained from Peprotech (London, UK). MMP inhibitor
(galardin, GM 6001) and its negative control were purchased from
Merck (Darmstadt, Germany) and used at a concentration of
10 mM. Before use, it was determined by 7AAD staining that this
concentration is not toxic for KCs.
MMP-9/TIMP-1 ELISA
MMP-9 complexed to TIMP-1 was measured with a commercial
sandwich ELISA (R&D Systems, Wiesbaden, Germany) allowing a
detection range of 3000–23pgml1. KCs were grown in 0.5ml of
hydrocortisone and epidermal growth factor-free medium on a 24-
well plate to 50–90% confluency. The cells were stimulated with
histamine receptor ligands at the indicated concentrations and for
the given periods of time. Cell-free supernatants were tested for
MMP-9/TIMP-1 levels according to the manufacturer’s instructions.
The plate was read at a wavelength of 450 nm on a FluoStar plate
reader (BMG Lab Technologies GmbH, Jena, Germany). For
data analysis, experiments with at least 100 pgml1 basal MMP-9
production in nonstimulated KCs were used.
mRNA isolation, reverse transcription, and quantitative RT-PCR
Human primary keratinocytes were stimulated with 10mM histamine
or left untreated for the indicated periods of time and lysed in
the well (no previous detachment or enzyme treatment). RNA
isolation was performed using High Pure mRNA Isolation Kit
(Roche Molecular Biochemicals, Mannheim, Germany) and reverse
transcription was done with First Strand cDNA Synthesis Kit
(MBI Fermentas, St Leon-Rot, Germany). Real-time quantitative
PCR was performed on a LightCycler (Roche Molecular Bio-
chemicals) using SYBR Green with Quantitect primer assays for
MMP-9 (QT00040040) and glyceraldehyde-3-phosphate dehydro-
genase GAPDH (QT01192646) according to manufacturer’s instruc-
tions (Qiagen, Hilden, Germany). The following settings were
used: an initial activation step of 15minutes at 951C with ramp
201C s1 was followed by three-step cycling (45 cycles): denatura-
tion 15 seconds, 941C; annealing 20 seconds, 551C; extension
20 seconds, 721C (all three with ramp 21C s1). Melting curve
analysis was performed from 60–901C with ramp 201C s1. The
amount of MMP-9 relative to the reference GAPDH was quantified
using the Relative Quantification Software (Roche Molecular
Biochemicals).
Gelatin zymography
Supernatants were taken from cultured KCs after 48 hours of
stimulation. Punch biopsies (3mm) were obtained from normal skin
obtained during plastic surgery or safety margin operations of skin
tumors from anonymous donors directly after surgery. A biopsy was
placed in 200 ml hydrocortisone and epidermal growth factor-free
medium in a 96-well round bottom plate and incubated for 16 hours
with 10 mM histamine or 0.3mM compound 48/80þ / 10 mM
clemastine. Thereafter, biopsies were placed in liquid nitrogen and
a homogenate was prepared. Protein extraction using mammalian
protein extraction solution (Pierce, Rockford, US) was done. The
protein content of supernatants and skin extracts was determined
using Bio-Rad Protein Assay Kit (Bio-Rad, Mu¨nchen, Germany). A
quantity of 10 mg of protein was diluted in Zymogram sample buffer
(Bio-Rad) and incubated for 10minutes at room temperature. The
samples were applied to a 10% gelatin gel (Ready Gel 10%
Zymogram gel with gelatin, Bio-Rad) and run at 200V for
150minutes. The gel was incubated by shaking for 30minutes at
room temperature in Zymogram renaturation buffer (Bio-Rad). Then
the gel was transferred to Zymogram development buffer (Bio-Rad)
and incubated for another 30minutes. Fresh development buffer
was used for incubation of the zymogram gel overnight at 371C.
The following day, the gel was stained for 60minutes in staining
solution (2.5 g Coomassie brilliant blue, 45% methanol, 45% H2O,
and 10% concentrated acetic acid) and destained (30% methanol,
60% H2O, and 10% concentrated acetic acid) until bands were
clearly visible.
Immunohistological staining
Three-millimeter punch biopsies from normal skin were placed in
200ml hydrocortisone and epidermal growth factor-free medium in
a 96-well round bottom plate and incubated for 16 hours with
medium alone or with histamine (10 mM). The biopsies were fixed
in formaldehyde, thereafter they were embedded in paraffin and
sections (2mm) were prepared.
For MMP-9 staining, the fixed sections were treated with Target
Retrieval Solution; polyclonal rabbit anti-human MMP-9 Ready-
to-use (NeoMarkers, Fremont, CA) and as isotype control rabbit
IgG (R&D Systems) at 1:100 dilution were used.
For type IV collagen staining, the fixed sections were treated with
Target Retrieval Solution (DakoCytomation, Hamburg, Germany)
and Proteinase K (DakoCytomation) to unmask epitopes. Mono-
clonal mouse antihuman type IV collagen, Clone CIV22 (Dako-
Cytomation), and as isotype control mouse IgG1 (DakoCytomation)
at 1:50 dilution were used.
Staining was performed according to the manufacturer’s instruc-
tions using the Dako Real Detection System, Alkaline Phosphatase/
Red, Mouse or Rabbit (DakoCytomation) in an automated immuno-
staining instrument (DakoCytomation).
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Transbasement membrane migration assay
The BD BioCoat growth-factor reduced Matrigel Invasion Chambers
(BD, Heidelberg, Germany) used in this experiment consist of a 24-
well plate and cell culture inserts with a membrane of 8mm pore
size. On top of the membrane, there is a layer of Matrigel Matrix that
serves as a reconstituted basement membrane in vitro and occludes
the pores of the membrane.
The chambers were rehydrated in keratinocyte medium for
2 hours (371C, 5% CO2, humidified atmosphere) before 4 104 KCs
were added to the insert. The adherent KCs were cultured as
nonstimulated control or treated with histamine (105M) for
30 hours. To check for specific effect of MMP, stimulation was
additionally done in combination with MMP inhibitor galardin (GM
6001) or an appropriate control. Galardin is a broad-spectrum
inhibitor that acts on MMP-1, MMP-2, MMP-3, MMP-8 and MMP-9
and chelates the zinc action in the active site of the proteases; the
control reagent with slightly different chemical formula has no
chelating activity. The next day, medium was replaced by Jurkat
growth medium, and to the bottom chamber a mix of chemo-
attractants, CCL2, CCL22, and CXCL10 (each 5 ngml1), was added.
This combination of cytokines was shown before to facilitate
migration of Jurkat cells through 8 mm membrane inserts (Corning
Inc./ Costar, New York, NY). To the insert, 5 105 Jurkat T cells were
added and the cells were allowed to migrate for 16 hours. The
amount of migrated cells was evaluated by transfer of the
resuspended cells of the bottom chamber to TruCount tubes (BD).
After acquisition of 10 000 fluorescence-labeled beads with a
FACScalibur Flow Cytometer (BD), the amount of migrated cells
was determined in relation to the counted beads, and the migration
index was calculated by dividing cell number by bead number.
Statistical analysis
For statistical evaluation of normal distributed data, the paired t-test
(Figures 1, 3, and 6) was used, and for data not normally distributed,
the Wilcoxon matched pairs test (Figure 2) was used; a P-value
below 0.05 was regarded as significant. Po0.05 is depicted with
* and Po0.005 with **. The program GraphPad Prism version
3.02 (GraphPad Software Inc., San Diego, CA) was used for
statistical analysis.
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